VentureMed Group (VMG) designs, develops and markets innovative and cost-effective medical devices for treating peripheral artery disease. VMG’s flagship product, the FLEX Scoring Catheter is an innovative and cost-effective plaque modification and vessel preparation catheter for scoring any length segment of the superficial-femoral artery (SFA), prior to balloon angioplasty or stent placement, and for emerging opportunities in drug coated balloon and drug eluting stent therapies. FLEX is the first and only one-size-fits-all alternative to cutting or scoring balloons and atherectomy devices.